Apixaban is safer than rivaroxaban in AF: study

Choosing between the two drugs is a choice between thrombotic or haemorrhagic risk

Apixaban is associated with a lower risk of major bleeding and thrombotic events compared with rivaroxaban, a large real-world data analysis shows.